Literature DB >> 28572219

Is replacement modality choice knowledge important in the non-renal multidisciplinary team? Experience from a single UK centre.

Fatima Abdelaal1, Hatem Ali2, Jyoti Baharani2.   

Abstract

Dialysis remains the mainstay treatment for patients with end stage renal disease. In the UK, there has been a significant decline in home dialysis despite its benefits and cost effectiveness. Patients with chronic kidney disease (CKD) are often known to other specialties who they may continue to consult when approaching dialysis. We wished to assess the knowledge of the non-renal multidisciplinary team (MDT) regarding home dialysis and establish whether further education was warranted. This was assessed using an online survey sent to specialties likely to deal with CKD patients. In total, 364 questionnaires were sent out with a 26.4% response rate. According to the survey responses, 81.5% of non-renal MDTs lack confidence in discussing home dialysis options with patients and 74.55% feel that they need further education about home dialysis. Targeted education may increase home dialysis uptake by multimorbid CKD patients who have a consistent message delivered by all relevant healthcare teams about the benefits of home dialysis. © Royal College of Physicians 2017. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; education; end stage renal disease; home dialysis; non-renal MDT

Mesh:

Year:  2017        PMID: 28572219      PMCID: PMC6297559          DOI: 10.7861/clinmedicine.17-3-198

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  28 in total

1.  At-home short daily hemodialysis improves the long-term health-related quality of life.

Authors:  Fredric O Finkelstein; Brigitte Schiller; Rachid Daoui; Todd W Gehr; Michael A Kraus; Janice Lea; Yoojin Lee; Brent W Miller; Marvin Sinsakul; Bertrand L Jaber
Journal:  Kidney Int       Date:  2012-05-23       Impact factor: 10.612

2.  Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis.

Authors:  Rajnish Mehrotra; Douglas Marsh; Edward Vonesh; Vickie Peters; Allen Nissenson
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

Review 3.  Perspectives in home hemodialysis therapy.

Authors:  Nicholas A Hoenich; Claudio Ronco
Journal:  Contrib Nephrol       Date:  2011-05-23       Impact factor: 1.580

Review 4.  The United States' perspectives on home dialysis.

Authors:  Mohammad Qamar; Filitsa Bender; Raymond Rault; Beth Piraino
Journal:  Adv Chronic Kidney Dis       Date:  2009-05       Impact factor: 3.620

Review 5.  Educational Interventions for Patients With CKD: A Systematic Review.

Authors:  Pamela A Lopez-Vargas; Allison Tong; Martin Howell; Jonathan C Craig
Journal:  Am J Kidney Dis       Date:  2016-03-26       Impact factor: 8.860

Review 6.  The advantages and disadvantages of home hemodialysis.

Authors:  Rosemary Masterson
Journal:  Hemodial Int       Date:  2008-07       Impact factor: 1.812

7.  A patient perspective on the barriers to home dialysis.

Authors:  Jonathon Hope
Journal:  J Ren Care       Date:  2013-01

8.  Increasing home dialysis knowledge through a web-based e-learning program.

Authors:  Paul N Bennett; Sadie Jaeschke; Peter M Sinclair; Peter G Kerr; Steve Holt; Monica Schoch; Debbie Fortnum; Cherene Ockerby; Bridie Kent
Journal:  Nephrology (Carlton)       Date:  2014-06       Impact factor: 2.506

9.  Thinking outside the box-identifying patients for home dialysis.

Authors:  Brigitte Schiller; Hayley Munroe; Andrea Neitzer
Journal:  NDT Plus       Date:  2011-12

Review 10.  The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies.

Authors:  R L Morton; A Tong; K Howard; P Snelling; A C Webster
Journal:  BMJ       Date:  2010-01-19
View more
  1 in total

1.  Targeting limited NHS resources to affect optimal care.

Authors:  Ed Nicol
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.